Mankind Pharma is an Indian pharmaceutical company that develops, manufactures, and markets a diverse range of pharmaceutical formulations and consumer healthcare products. The company’s portfolio includes a broad spectrum of treatments for various therapeutic areas, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neurology, vitamins, minerals, and respiratory health.
The company’s product range is vast, with over 200 products, including prescription and over-the-counter (OTC) branded products. Its portfolio of brands covers women’s health, fertility, and critical care, with multiple brands present in each therapy area. Some of its notable brands include Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, and Dynaglipt, among others.
Mankind Pharma has a strong presence in the Indian market, with several subsidiaries, including Lifestar Pharma Private Limited, Magnet Labs Private Limited, and Jaspack Industries Private Limited, to name a few. The company’s portfolio is constantly evolving, with a focus on innovation, quality, and reliability, to provide effective and affordable healthcare solutions to its customers. With a wide range of products and a strong distribution network, Mankind Pharma is a significant player in the Indian pharmaceutical industry.